University of California, Davis

UC Davis Graduate School of Management Announces Partnership With NBA’s Sacramento Kings

Retrieved on: 
Tuesday, January 9, 2024
Professional Services, Basketball, Education, Business, Sports, University, Training, Partnership, Golden 1 Center, Golden, Student, UC, Postgraduate education, NBA, Business operations, Sport, Master, Management, University of California, Davis, Organization, Utah Jazz, Master of Management, Nursing

“The Sacramento Kings have had a positive impact on many aspects of the greater Sacramento community, much like UC Davis,” said H. Rao Unnava, the Michael and Joelle Hurlston Dean of the UC Davis Graduate School of Management.

Key Points: 
  • “The Sacramento Kings have had a positive impact on many aspects of the greater Sacramento community, much like UC Davis,” said H. Rao Unnava, the Michael and Joelle Hurlston Dean of the UC Davis Graduate School of Management.
  • “This partnership is the joining of two organizations with focus on providing high-quality education and career growth opportunities to the thriving community in this region.”
    “We are excited to partner with UC Davis Graduate School of Management to promote their new Master of Management Program and further our Fastbreak Mentoring Program,” said Sacramento Kings President of Business Operations John Rinehart.
  • In December, UC Davis Graduate School of Management was recognized as the presenting partner of the annual “College Night” theme game when the Kings hosted the Utah Jazz.
  • UC Davis Graduate School of Management is also a presenting partner of the Kings Fastbreak Mentoring Program in collaboration with Mentor California, giving UC Davis MBA students the opportunity to use their diverse expertise to connect with local youth and community.

ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration

Retrieved on: 
Friday, January 5, 2024
RNA, Methyl group, Partnership, Rett syndrome, Research, ProQR, UC, Eon, RSRT, CNS, University of California, Davis, MECP2, Pharmaceutical industry

“The Rett Syndrome Research Trust is the leading patient advocacy group championing a cure for Rett syndrome and we look forward to collaborating with them to further expand the broad applicability of our Axiomer RNA editing technology to Rett syndrome, a rare neurodevelopment disorder with significant unmet medical need,” said Daniel A. de Boer, Chief Executive Officer of ProQR.

Key Points: 
  • “The Rett Syndrome Research Trust is the leading patient advocacy group championing a cure for Rett syndrome and we look forward to collaborating with them to further expand the broad applicability of our Axiomer RNA editing technology to Rett syndrome, a rare neurodevelopment disorder with significant unmet medical need,” said Daniel A. de Boer, Chief Executive Officer of ProQR.
  • “Axiomer has the potential to restore precise levels of the MECP2 protein, which is lacking in Rett syndrome.
  • It is the intent of the partnership to be continued by an expanded co-funding arrangement following the initial discovery work.
  • The co-funding of the next phase of the collaboration would enable clinical development of an Axiomer-based therapeutic for Rett syndrome MECP2.

Wilridge Winery Looks Back at 35 Years of Being Washington’s Greenest Winery and a Mover of State Wine Regulations

Retrieved on: 
Wednesday, November 22, 2023
Moon, Prohibition, Learning, Sale, Eastern Washington, Agriculture, Pacific Northwest, Farm, Taste, Health, Herbicide, UC, Wine, Beer, World War I, Calendar, Food, Pesticide, Episcopal, University of California, Davis, Safety, Life

Wilridge Winery , a family-owned vineyard, orchard, winery and distillery headquartered in Seattle, Washington, is marking its 35th year in business.

Key Points: 
  • Wilridge Winery , a family-owned vineyard, orchard, winery and distillery headquartered in Seattle, Washington, is marking its 35th year in business.
  • As the first certified organic, Biodynamic vineyard and winery in the state, Wilridge lays claim to the title of Washington’s greenest winery.
  • Founded in 1988 by former environmental lawyer Paul Beveridge, Wilridge has also contributed to changes in laws governing the sale of wine and alcoholic beverages in the State of Washington.
  • However, Washington still had “tied house” laws that prohibited manufacturers of alcoholic beverages from owning retail outlets that sold wine.

Graham Christie Named COO of the Alameda Corridor Transportation Authority

Retrieved on: 
Thursday, December 14, 2023
Public Transport, Rail, Transport, Other Transport, University of California, Davis, Civil engineer, Port of Long Beach, Safety, Federal Railroad Administration, Congestion, ACTA, Multimedia, City, California Public Utilities Commission, Corridor, University, Public utilities commission, Alameda Street, Rail transport by country, Disinformation Governance Board, Port, AECOM, Management, Rail transport

The Governing Board of the Alameda Corridor Transportation Authority (ACTA) has appointed Graham Christie, a Southern California rail leader and seasoned project manager, as Chief Operating Officer (COO).

Key Points: 
  • The Governing Board of the Alameda Corridor Transportation Authority (ACTA) has appointed Graham Christie, a Southern California rail leader and seasoned project manager, as Chief Operating Officer (COO).
  • View the full release here: https://www.businesswire.com/news/home/20231214300214/en/
    Rail industry veteran Graham Christie has been appointed Chief Operating Officer of the Alameda Corridor Transportation Authority.
  • This background and proven success make Graham the ideal choice as COO,” said Michael Leue, ACTA Chief Executive Officer.
  • The addition of a COO to ACTA’s leadership structure was the result of an analysis of the Authority’s operation.

Sheppard Mullin Lands Estate Planning, Private Wealth and Fiduciary Litigation Team in San Diego

Retrieved on: 
Tuesday, December 12, 2023
Professional Services, Other Construction & Property, Legal, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Transfer, Coif, Elder abuse, Organization, Wealth, University, Tax, Paschoal Silva, University of California, Davis, Bar association, Trust, American College, News, Steven Naifeh, Estate planning, Family, Lawyer, Santa Clara University, Real estate, Property management, Life insurance

“We are delighted to welcome Jenny, Matt and their team to Sheppard Mullin,” said Luca Salvi, chair of Sheppard Mullin.

Key Points: 
  • “We are delighted to welcome Jenny, Matt and their team to Sheppard Mullin,” said Luca Salvi, chair of Sheppard Mullin.
  • “Our Private Wealth and Fiduciary Litigation and our Estate Planning and Wealth Transfer practices are nationally and internationally recognized for their successes in the courtroom and their innovative approach to estate, tax and succession planning.
  • Owens joins Sheppard Mullin’s Business Trial practice group where he will be a part of its renowned Private Wealth and Fiduciary Litigation team.
  • Paschoal is an associate in the Tax practice group and Estate Planning and Wealth Transfer team practicing in the areas of estate planning, trust and estate administration, charitable giving and tax-exempt organizations.

Supply Chain Operations Expert Michael Ziomek is Named New COO of Odyssey Logistics

Retrieved on: 
Monday, December 11, 2023
Software, Data Management, Trucking, Rail, Technology, Logistics, Supply Chain Management, Air, Transport, Sale, Economics, Rite Aid, Intermodal transport, University, Ziomek, Food, University of California, Davis, Multimedia, Managed services, Master, Smith & Nephew, Alberico, Warehouse, Business administration, Ingram Micro, Smith, Clorox, Master of Business Administration, Video game, Science, Odyssey

Odyssey Logistics (Odyssey), a global leader in logistics and technology solutions, announced that Michael Ziomek has been appointed chief operating officer effective December 11.

Key Points: 
  • Odyssey Logistics (Odyssey), a global leader in logistics and technology solutions, announced that Michael Ziomek has been appointed chief operating officer effective December 11.
  • With 30 years in leadership roles in supply chain logistics, warehousing and distribution, Ziomek comes aboard Odyssey as the company advances its growth strategy, transitions to a unified Odyssey brand and aims to enhance customer experiences worldwide.
  • View the full release here: https://www.businesswire.com/news/home/20231211295781/en/
    Odyssey Logistics announces Michael Ziomek as their new COO (Photo: Business Wire)
    “Michael has an impressive track record of steering complex global operations, managing teams and leveraging technology for the benefit of customers,” said Hans Stig Moller, CEO of Odyssey.
  • Ziomek will lead operational strategy and management for the company’s four core divisions — Integrated Marine Logistics, Intermodal, Managed Services and Transport & Warehouse, under a unified Odyssey brand.

Dan Berry Joins Alliant Insurance Services as Venture Capital Leader, Executive Vice President; Strengthens M&A/Private Equity Specialty

Retrieved on: 
Thursday, December 7, 2023
Finance, Consulting, Professional Services, Small Business, Insurance, Alliant, University of California, Davis, Risk management, Marine Corps Expeditionary Medal, University, Financial services

Dan Berry has joined Alliant Insurance Services as Venture Capital Leader, Executive Vice President, Alliant M&A.

Key Points: 
  • Dan Berry has joined Alliant Insurance Services as Venture Capital Leader, Executive Vice President, Alliant M&A.
  • Based in San Francisco, Berry brings specialized expertise in the risk management and insurance needs of venture capital and private equity firms and their portfolio companies.
  • He has worked with hundreds of venture capital and private equity firms to help protect hundreds of billions of dollars in assets under management.
  • Berry previously served as the private equity and venture capital group leader at a leading national brokerage firm.

Bayer Announces Publication of Health Economic Model Evaluation at RSNA, Providing New Insights Into Cost Effectiveness and Capacity Needs of Supplemental Screening Modalities for Dense Breasts

Retrieved on: 
Monday, November 27, 2023
Biotechnology, Pharmaceutical, Health, Oncology, Woman, Mammography Quality Standards Act, CEM, Literature, Risk, XM, Journal of Medical Economics, Breast cancer, Patient, Journal, FDA, Medical Affairs Bureau, Bayer, American College, Markov, Breast MRI, Adrian Dixon, University, DBT, Congress, MRI, Cancer, ACR, University of California, Davis, U/S, Medical imaging

Bayer announced today the publication of a novel health economic model in the Journal of Medical Economics , funded by Bayer, analyzing cost effectiveness and infrastructural capacity of supplemental imaging modalities for women with dense breasts at average or intermediate risk of breast cancer.

Key Points: 
  • Bayer announced today the publication of a novel health economic model in the Journal of Medical Economics , funded by Bayer, analyzing cost effectiveness and infrastructural capacity of supplemental imaging modalities for women with dense breasts at average or intermediate risk of breast cancer.
  • Though U/S seemed more advantageous from a purely economic perspective, MRI and CEM offered the best clinical outcomes.
  • “The results of this study point to the clinical value and economic viability of contrast-enhanced modalities for supplemental breast cancer screening for women with dense breasts.
  • Sensitivity and specificity values for XM and DBT and supplemental screening modalities were taken from the literature.

United States Transdermal Patch Market Report 2023: Dosage, Price & Clinical Trials Insights to 2029 - Focus on Opioid, Cardiovascular Diseases, Neurological Disorders, and Hormonal Therapy - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 23, 2023
Medical Devices, Health, Gastritis, Brown University, Transdermal patch, Research, Indication, Chronic pain, Parkinson's disease, Pain management, Buprenorphine, University of California, Davis, Pregnancy, Patient, FDA, Alzheimer's disease, Opioid use disorder, Zydus Lifesciences, University, Cancer, Communication, Pain, Growth, Nerve, DSM-IV codes, Generic drug, Pharmaceutical industry, Adhesive, Birth control

The "US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering.
  • With the rapid approvals of transdermal patches lately, the FDA has also marked itself as an important player in the US market of transdermal patches.
  • The FDA provides a detailed communication on the requirements of an ideal transdermal patch, and patches that meet these are allowed entry in the regional market.
  • US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2029 Report Highlights:
    US Transdermal Patch Market Opportunity: > US$ 5 Billion By 2029
    Commercially available Patches In US Market: > 25 Patches
    Ongoing Clinical Trials Of Transdermal Patches in US: > 40 Patches
    US Transdermal Patch Clinical Trials Insight By Company, Indication & Phase

BioIntelliSense and UC Davis Health Launch Continuous Monitoring Program for Bone Marrow Transplant Patients

Retrieved on: 
Thursday, November 16, 2023
Wearables, Mobile Technology, Biometrics, Other Health, Artificial Intelligence, Oncology, Software, Medical Devices, Hardware, Hospitals, Professional Services, Technology, General Health, Biotechnology, Data Analytics, Surgery, Health, University, Health Technology, Education, Risk, Respiratory rate, Patient, Sleep medicine, Rest, FDA, CIO, Digital, MD, Skin temperature, University of California, Davis, News, Vital signs, Critical care, UC, UC Davis Health Stadium, Medical imaging, Nursing, Pharmaceutical industry

BioIntelliSense , a continuous health monitoring and clinical intelligence company, and California-based UC Davis Health announce the launch of a new in-hospital monitoring initiative for patients hospitalized for Bone Marrow Transplant and Hematology/Oncology services.

Key Points: 
  • BioIntelliSense , a continuous health monitoring and clinical intelligence company, and California-based UC Davis Health announce the launch of a new in-hospital monitoring initiative for patients hospitalized for Bone Marrow Transplant and Hematology/Oncology services.
  • “Smart care is the future of healthcare, and we are delivering on that promise with the introduction of this continuous care program at UC Davis Health.”
    An award-winning academic medical center, UC Davis Health is a recognized leader in advancing digital transformation initiatives focused on equitable, accessible, and cost-effective patient care.
  • The BioIntelliSense project has been led and driven by the cutting-edge UC Davis Health Digital CoLab and their commitment to identifying, evaluating, and implementing best-in-class technologies and programs.
  • “We want to empower our clinical teams with the most advanced tools available, so they can effectively and efficiently personalize every patient’s care.